JPRN-UMIN000002390
Completed
Phase 4
Study to examine the effects of Salmeterol/fluticasone propionate combination(SFC) in patients with cough variant asthma(CVA) - Study to examine the effects of SFC in CVA
Kyoto University Graduate School of Medicine0 sites60 target enrollmentAugust 26, 2009
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyoto University Graduate School of Medicine
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients without cough symptom in the last 1 week before enrollment 2\)Patients with other respiratory diseases 3\)Patients taking Long acting be\-ta 2 agonist(LABA) or Leukotriene receptor antagonist(LTRA) 4\)Patients who are given systemic corticosteroid in the last 4 weeks 5\)Patients who suffered from upper respiratory infection in the last 4 weeks 6\)Patients who had smoked in the last 6 months, or who had smoked more than 10 pack year in the past 7\)Patients who are considered inappropriate by physicians in charge
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease by Impulse OscillometryChronic Obstructive Pulmonary DiseaseJPRN-UMIN000004196St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases200
Completed
Not Applicable
Comparison of Clinical Effects of Salmeterol/Fluticasone Propionate Combination Products Delivered via Metered-Dose Inhaler with Dry Powder Inhaler in Patients with Moderate AsthmaBronchial asthmaJPRN-UMIN000009990ational Center for Global Health and Medicine40
Completed
Phase 4
Study Of Fluticasone Propionate/Salmeterol In Asthmatic SubjectsAsthmaNCT00517634GlaxoSmithKline23
Completed
Phase 3
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable TabletsAsthmaNCT00328718GlaxoSmithKline526
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-LTHEXAL AG472